The platform aims to offer more consistent and precise characterization at diagnosis and tracking of fibrosis in patients with metabolic dysfunction-associated steatohepatitis.Â
New research suggests standard drug tests may miss low-level exposure in children—potentially sending them back into unsafe home environments—and suggests an alternative.
Despite powerful advances in precision medicine, most doctors remain untrained in these emerging diagnostic tools.
The increasing demand for laboratory tests presents a unique challenge for clinical labs already battling staffing shortages.
Digital pathology has traditionally been associated with large academic institutions, but recent advancements have made it accessible for mid-sized and community hospital labs.
As labs aim to minimize disruptions, they are increasingly investing in strategies focused on resilience and rapid recovery.
Flow cytometers are becoming increasingly compact and sophisticated, offering opportunities and challenges for routine clinical use.
MeMed has unveiled MeMed BV Flex, a rapid fingerstick-based test that distinguishes bacterial from viral infections in 15 minutes.
Rapid immunoassays have emerged as a valuable tool for providing quick information that can be crucial in life-threatening situations.
Researchers have developed a blood-based proteomics model that accurately predicts disease progression in ADPKD.
Bruker's MALDI Biotyper sirius and sirius one systems have received the ACT Label from My Green Lab, recognizing responsible design.
As accessibility to long-read sequencing technologies like Oxford Nanopore and PacBio increases, clinical laboratories must assess their readiness for implementation.
Labcorp and NOWDiagnostics have partnered to distribute free First to Know Syphilis Test kits to public health organizations nationwide.
Many clinical laboratories are using outdated urine analyzers, which may affect efficiency and data accuracy.